Delivery Order SPE2DB22D2007-SPE2DB23FJ3VE

Award Date 7/5/23
Potential Completion Date 7/6/23
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,843 delivery order contract to Amerisourcebergen Drug Corporation for 5 mg vials of the chemotherapy drug mitomycin. As a prime contractor for DLA's pharmaceutical supply program, Amerisourcebergen will deliver the vials to a customer located in Conshohocken, Pennsylvania. The firm fixed price order is for a one-day period of performance from July 25 to July 26, 2023, to fulfill a customer's near-term chemotherapy needs. No subcontractors or set aside...
The Defense Logistics Agency awarded a $5,326 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562312732 units of 5 mg Mitomycin vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by September 27, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $565 to Amerisourcebergen Drug Corporation to supply 4561985811 Mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the order. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies for the U.S....
The Defense Logistics Agency awarded a $733.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4561436388 mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the agency's location in Conshohocken, Pennsylvania by July 10, 2023 under the terms of this short-term order. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to provide...
The Defense Logistics Agency awarded a $6,758 delivery order to Amerisourcebergen Drug Corporation for 4562195244 mitomycin 20 mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 18, 2023 under the firm fixed price contract awarded on September 15, 2023. The Defense Logistics Agency utilizes indefinite delivery/indefinite quantity contracts to support medical readiness for the Department of...
The Defense Logistics Agency awarded a $6,085.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562179137 mitomycin 40 mg vials. The prime contractor will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by September 15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This small order for cancer treatment...
The Defense Logistics Agency awarded a $337 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation to provide 4562066016 Mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 7, 2023 under the terms of the order. No subcontractors or set aside designations were specified. The Defense Logistics Agency supports Department of Defense procurement programs through...
The Defense Logistics Agency Troop Support Medical awarded a $545.67 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562251488 mitomycin 5 mg vials. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA Troop Support and the Department of Defense medical community. Amerisourcebergen will deliver the mitomycin vials to its place of performance in Conshohocken, Pennsylvania by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,667.25 firm fixed-price contract is for the provision of 40 mg vials of the drug mitomycin, a chemotherapy medication. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,385.07 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 5 mg vials of the chemotherapy drug mitomycin. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 9-10, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the U.S. Armed Forces by procuring pharmaceuticals and...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB23FJ3VE
    Delivery Order

Defense Logistics Agency, an agency of the Department of Defense, awarded a $10,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561406930 units of the chemotherapy drug mitomycin at 40 mg per vial. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. The delivery order was issued under an existing Prime Vendor contract vehicle to supply pharmaceuticals and other medical commodities in support of DOD treatment programs. No subcontractors or set aside designations were identified.

Generated 12/17/23, 7:49 PM